Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs IND SWIFT LA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA IND SWIFT LA ORCHID PHARMA/
IND SWIFT LA
 
P/E (TTM) x 41.8 13.0 321.8% View Chart
P/BV x 7.7 0.9 903.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ORCHID PHARMA   IND SWIFT LA
EQUITY SHARE DATA
    ORCHID PHARMA
Mar-23
IND SWIFT LA
Mar-23
ORCHID PHARMA/
IND SWIFT LA
5-Yr Chart
Click to enlarge
High Rs43977 569.5%   
Low Rs27351 534.4%   
Sales per share (Unadj.) Rs163.1204.3 79.8%  
Earnings per share (Unadj.) Rs13.58.1 167.2%  
Cash flow per share (Unadj.) Rs27.017.8 151.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs168.7115.4 146.2%  
Shares outstanding (eoy) m40.8259.09 69.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.20.3 695.7%   
Avg P/E ratio x26.37.9 332.2%  
P/CF ratio (eoy) x13.23.6 366.9%  
Price / Book Value ratio x2.10.6 380.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m14,5223,785 383.7%   
No. of employees `000NANA-   
Total wages/salary Rs m6541,262 51.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m6,65912,073 55.2%  
Other income Rs m194335 58.0%   
Total revenues Rs m6,85312,408 55.2%   
Gross profit Rs m1,2352,026 61.0%  
Depreciation Rs m548574 95.5%   
Interest Rs m329922 35.7%   
Profit before tax Rs m552865 63.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0387 0.0%   
Profit after tax Rs m552478 115.5%  
Gross profit margin %18.516.8 110.6%  
Effective tax rate %044.7 0.0%   
Net profit margin %8.34.0 209.4%  
BALANCE SHEET DATA
Current assets Rs m5,01011,631 43.1%   
Current liabilities Rs m3,7193,711 100.2%   
Net working cap to sales %19.465.6 29.6%  
Current ratio x1.33.1 43.0%  
Inventory Days Days5710 549.8%  
Debtors Days Days1,1801,528 77.2%  
Net fixed assets Rs m7,2426,297 115.0%   
Share capital Rs m408598 68.2%   
"Free" reserves Rs m6,4786,221 104.1%   
Net worth Rs m6,8866,819 101.0%   
Long term debt Rs m1,4887,526 19.8%   
Total assets Rs m12,25217,942 68.3%  
Interest coverage x2.71.9 138.2%   
Debt to equity ratio x0.21.1 19.6%  
Sales to assets ratio x0.50.7 80.8%   
Return on assets %7.27.8 92.2%  
Return on equity %8.07.0 114.4%  
Return on capital %10.512.5 84.5%  
Exports to sales %81.973.4 111.6%   
Imports to sales %37.60-   
Exports (fob) Rs m5,4528,859 61.5%   
Imports (cif) Rs m2,501NA-   
Fx inflow Rs m5,4528,859 61.5%   
Fx outflow Rs m2,726285 956.6%   
Net fx Rs m2,7268,574 31.8%   
CASH FLOW
From Operations Rs m1831,946 9.4%  
From Investments Rs m-312-134 233.5%  
From Financial Activity Rs m312-1,857 -16.8%  
Net Cashflow Rs m183-44 -415.1%  

Share Holding

Indian Promoters % 69.8 42.0 166.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 18.6 19.0 97.9%  
FIIs % 4.1 0.3 1,335.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.2 58.0 52.0%  
Shareholders   36,931 24,633 149.9%  
Pledged promoter(s) holding % 0.0 86.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Orchid Pharma vs IND SWIFT LA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Orchid Pharma vs IND SWIFT LA Share Price Performance

Period Orchid Pharma IND SWIFT LA S&P BSE HEALTHCARE
1-Day -0.40% 2.56% 1.18%
1-Month -14.06% -7.66% -0.75%
1-Year 173.54% 81.37% 61.82%
3-Year CAGR -23.64% 10.40% 18.16%
5-Year CAGR 184.58% 19.70% 19.79%

* Compound Annual Growth Rate

Here are more details on the Orchid Pharma share price and the IND SWIFT LA share price.

Moving on to shareholding structures...

The promoters of Orchid Pharma hold a 69.8% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Orchid Pharma and the shareholding pattern of IND SWIFT LA.

Finally, a word on dividends...

In the most recent financial year, Orchid Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Orchid Pharma, and the dividend history of IND SWIFT LA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.